Optimizing Expanded Access

Optimizing Expanded Access

Choosing Durbin as your 360° tech-enabled EAP partner replaces risk with certainty and control. Your expanded access programs are optimized to meet your commercialization and development objectives, to make a positive impact for your product and the patients, and to provide the best level of service and care to the healthcare providers (HCPs) and other stakeholders.  

Optimizing Expanded Access

Choosing Durbin as your 360° tech-enabled EAP partner replaces risk with certainty and control. Your expanded access programs are optimized to meet your commercialization and development objectives, to make a positive impact for your product and the patients, and to provide the best level of service and care to the healthcare providers (HCPs) and other stakeholders.  

Optimizing Expanded Access

Our Story of Running Expanded Access Programs

We have been successfully running Expanded Access Programs for pharmaceutical and biotechnology manufacturers on a global scale for over 25 years. Here is a look at some of the significant milestones we have reached on the way to becoming the experts in early access programs.  

1963

Durbin brothers open their first retail pharmacy in Harrow, North West London 

Harrow
1977

International Sales division founded and first warehouse opened in London

1995

Expanded Access Programs (EAPs) division launched 

Harrow
2002

Unlicensed Medicine (Imports) launched

Harrow
2005

Durbin celebrates launching its 25th Expanded Access Program in rare disease and oncology 

Harrow
2009

Second warehouse and fourth office opens  in UK 

Warehouse
2013

Durbin celebrates its 50th year in business by acquiring a U.S. branch. Durbin USA is formed to strengthen the global delivery of Expanded Access Programs 

Warehouse
2018

New 70,000 sq.ft. London warehouse and HQ opens 

Uniphar
2019

Durbin’s acquisition by Uniphar Group adds diversified healthcare service capabilities and 300,000+ square feet of new warehouse infrastructure in Benelux and Ireland 

Uniphar
2020

Durbin appointed to run world’s largest gene therapy EAP for a rare neuromuscular disease 

Uniphar

Award Winning Industry Leader

Durbin's continued commitment to excellence and contribution to the pharmaceutical industry has been honored with multiple prestigious awards over the years.

2018

Winner of The Queen’s Awards for Enterprise: International Trade 2018 and The President’s “E Star” Award for Export Excellence

2017

Winner of Exporter/International Business of the Year at the West London Business Awards 2017

Ranked No. 68 in the 18th Sunday Times BDO Profit Track 100 list

Awarded The Mississippi (USA) District Export Council “Governor”s Award for Exporting 2017

 

2016

Winner of Most Outstanding Medical Supply Firm, U.K. at Corporate LiveWire Innovation & Excellence Awards

Winner of Export Excellence in Americas category at the U.K. Export Excellence Awards
 

2014

Durbin is named National Champion at the European Business Awards.

2013

Winner of the Exporter/International Business of the Year award at the West London Business Awards.

2012

Winner of International Business of the Year at the Business Excellence Awards, and runner up in the Large Business of the Year category.


Expanded Access Capabilities

Expanded Access Capabilities

Durbin provides optimal value and a full scope of EAP capabilities to support programs and sponsors of any size:

  • Asset-centric design of the program 
  • Development of regulatory strategy 
  • Global project management
  • Full scale of regulatory support in 180+ countries
  • End-to-end supply chain management
  • Pharmaceutical warehousing 
  • EAP drug safety
  • Physician and patient support 
  • Proprietary RWD management, re-ordering and EAP management system
  • Real-time data and metrics insight
  • RWD strategy optimization

We pride ourselves on delivering best-in-class expanded access services to the pharmaceutical industry, with a personal touch and true passion for patient outcomes.

Expanded Access Capabilities

Expanded Access Capabilities

Durbin provides optimal value and a full scope of EAP capabilities to support programs and sponsors of any size:

  • Asset-centric design of the program 
  • Development of regulatory strategy 
  • Global project management
  • Full scale of regulatory support in 180+ countries
  • End-to-end supply chain management
  • Pharmaceutical warehousing 
  • EAP drug safety
  • Physician and patient support 
  • Proprietary RWD management, re-ordering and EAP management system
  • Real-time data and metrics insight
  • RWD strategy optimization

We pride ourselves on delivering best-in-class expanded access services to the pharmaceutical industry, with a personal touch and true passion for patient outcomes.


Durbin - a Uniphar company

Durbin is part of the Product Access Division at Uniphar (LON: UPR). Being a Uniphar company, Durbin harness the capabilities, infrastructure, experience, and expertise of a diversified pharmaceutical service provider with over 55 years of building success stories with more than 200 multinational clients.

Uniphar Group logo

Durbin - a Uniphar company
Durbin - a Uniphar company

Durbin - a Uniphar company

Durbin is part of the Product Access Division at Uniphar (LON: UPR). Being a Uniphar company, Durbin harness the capabilities, infrastructure, experience, and expertise of a diversified pharmaceutical service provider with over 55 years of building success stories with more than 200 multinational clients.

Uniphar Group logo